<DOC>
	<DOCNO>NCT02989948</DOCNO>
	<brief_summary>A prospective , single-arm , traditional feasibility study physician-modified fenestrated Cook Zenith TX2 aortic endograft base device adult patient meet traditional size criterion open surgical treatment thoracoabdominal aortic aneurysm . Patients merit surgical treatment aneurysm also meet inclusion exclusion criterion eligible enrollment . Patients follow 5 year post procedure . Major adverse event also record Sponsor-Investigator monitor locally appoint Data Monitoring Committee , Colorado Multiple Institutional Review Board , FDA .</brief_summary>
	<brief_title>Physician-Modified Fenestrated Branched Aortic Endografting TAAA</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Thoracic</mesh_term>
	<criteria>1 . Must man woman 50 year age old date inform consent . 2 . Must thoracoabdominal aortic aneurysm Crawford classification ( extent IV ) extend proximal left subclavian artery . 3 . Must aneurysm size meet standard indication surgical repair ( 6.0 cm maximum diameter descend thoracic aorta , 5.5 cm maximum diameter abdominal aorta ) . 4 . Must consider , judgment SI , high risk candidate open surgical repair . 5 . Must candidate repair Instructions Use commercially available , FDAapproved endovascular graft . 6 . Patient LAR must able provide inform consent . 7 . Must able comply five year study assessment schedule event . 8 . Must nonaneurysmrelated life expectancy , judgment SI , great 2 year . 1 . Aneurysm due acute chronic dissection , intramural hematoma , penetrate aortic ulceration , pseudoaneurysm , mycotic aneurysm , traumatic transection . 2 . Ruptured acutely symptomatic aortic aneurysm . 3 . Known connective tissue disorder . 4 . Imaging demonstrate follow : Lack 20 mm nonaneurysmal proximal seal zone ( zone 3 , zone 2 carotidsubclavian bypass transposition ) . Lack 15 mm nonaneurysmal distal seal zone ( ) ( aortic , common iliac , external iliac ) . Branch vessel target ( renal , superior mesenteric , celiac ) &lt; 5 mm &gt; 10 mm average diameter . Untreated leave subclavian artery stenosis occlusion . Untreated unilateral bilateral hypogastric artery occlusion . Signs inferior mesenteric artery indispensable . Have branching , duplication , aneurysm , untreatable stenosis celiac , superior mesenteric artery , renal artery would preclude implantation investigational device . 5 . Known allergy stainless steel polyester . 6 . History anaphylaxis contrast , inability prophylax appropriately . 7 . Have uncorrectable coagulopathy . 8 . Have unstable angina . 9 . Have body habitus would inhibit Xray visualization aorta . 10 . Have major surgical interventional procedure unrelated treatment aneurysm plan â‰¤30 day endovascular repair . 11 . Known participate clinical study may affect performance device . 12 . Known visible pregnancy . 13 . Contraindication oral antiplatelet therapy . 14 . Prisoners alternative sentencing . 15 . Known systemic infection potential endovascular graft infection . 16 . Anticipated need MRI scan within 3 month insertion investigational product . 17 . Other condition comorbidities , opinion SponsorInvestigator , would exclude patient .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Endovascular</keyword>
</DOC>